EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen, Js;Landewé, R;Bijlsma, J;Burmester, G;Chatzidionysiou, K;Dougados, M;Nam, J;Ramiro, S;Voshaar, M;van Vollenhoven, R;Aletaha, D;Aringer, M;Boers, M;Buckley, Cd;Buttgereit, F;Bykerk, V;Cardiel, M;Combe, B;CUTOLO, MAURIZIO;van Eijk Hustings, Y;Emery, P;Finckh, A;Gabay, C;Gomez Reino, J;Gossec, L;Gottenberg, Je;Hazes, Jm;Huizinga, T;Jani, M;Karateev, D;Kouloumas, M;Kvien, T;LI, ZHIBIN;Mariette, X;Mcinnes, I;Mysler, E;Nash, P;Pavelka, K;Poór, G;Richez, C;van Riel, P;Rubbert Roth, A;Saag, K;da Silva, J;Stamm, T;Takeuchi, T;Westhovens, R;de Wit, M;van der Heijde, D.

2017-01-01